8/30/2019Xynomic Pharma Reports Encouraging Data on Lead Cancer Drug

8/30/2019NHSA Issues Guidance Policy for Prices and Reimbursement of Internet +...

8/30/2019Recent Executive Moves

8/30/2019NHC Sets Up Pediatric and Oncology Expert Committees

8/29/2019Over 180 Chinese Pharma Public Cos Release 2019 Mid-Year Results

8/28/2019PPD, Harbour Biomed Enter Parntnership for Oncology and Immunology Dru...

8/27/2019iBio and CC-Pharming Enter China Licensing Pact for Bio-better Rituxim...

8/27/2019China's Latest Tariff Hike on US Goods Affects Drugs Under At Least 30...

8/27/2019China Boosts Leniency for Limited Import of Unapproved Drugs

8/27/2019NHC Issues List of Pediatric Drugs Encouraged for R&D and Registra...

8/26/201921 Chinese Pharma Companies Made It to the Fortune China 500

8/26/2019SMEI: Top Chemical Drug Products in Urban Chinese Retail Pharmacies 20...

8/26/2019IQVIA: Overall Chinese Pharma Market Growth Slowed to 4.5% in 2018

8/26/2019Review of Chinese Drug Evaluation and Registration in 2018

8/26/2019Review of Chinese Pharma Deals, R&D and Regulatory Developments in...

8/23/2019Chi-Med Initiates Phase I Trial of HMPL-523 for Immune Thrombocytopeni...

8/23/2019111 Signs Strategic Partnership with TK.CN to Empower PBM and Insuranc...

8/23/2019China to Step Up Crackdown on Drug Monopoly to Keep Prices and Supply ...

8/21/2019China's Biopharma Strategy: Challenge or Complement to U.S. Industry C...

8/21/2019Innovent Enters a Licensing Agreement with Lilly to Develop & ...

8/21/2019Alligator Bio and Biotheus Enter Antibody Agreement for Greater China

8/21/2019USFDA Grants Priority Review to BeiGene's Zanubrutinib in Patients wit...

8/21/2019CMAB and Kintor Announce a New Partnership to Develop and Manufacture ...

8/20/2019China's Central Government Introduces Major Policy Incentives and Rest...

8/20/2019Chronic and Aging-related Diseases Cost Over Half of Chinese BMI Spend...

8/19/2019NMPA Issues the Administrative Measures for Drug Quality Sampling Insp...

8/19/2019CitiResearch - China at Inflection Point: Big Opportunity for MNCs, Do...

8/19/2019Sanofi Gains Chinese IND Approval for RNAi Therapy Fitusiran Injection

8/16/2019Regulator Penalizes 22 at Kangmei for $12.6 Billion of Overstatements

8/16/2019China to Enhance Common Medicine Supply through New Measures

Page:138/361 Total number of articles:10826: [First][<<] [136] [137] [138] [139] [140] [>>] [End]